- In March 2024, Ariceum Therapeutics launched a radiopharmaceutical laboratory in Berlin, which will facilitate internal research and development for its upcoming pipeline candidates
- In March 2024, Ratio Therapeutics Inc. announced an expanded manufacturing agreement with PharmaLogic, a leading contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals. This collaboration aims to accelerate the production and market introduction of Ratio's advanced radiotherapies, particularly its candidate targeting fibroblast activation protein (FAP)
- In March 2024, Telix Pharmaceuticals completed the acquisition of ARTMS Inc. for up to USD 82 million, enhancing its capabilities in radiopharmaceuticals. The acquisition provided access to state-of-the-art isotope production technology, a manufacturing facility, and a stockpile of ultrapure rare metals, strengthening Telix's position in the industry
- In February 2024, Bayer strengthened its collaboration with PanTera by securing actinium-225 for the development of innovative radiopharmaceuticals. This partnership represented PanTera's first engagement with a major pharmaceutical company, initiating the provision of clinical trials in the latter half of the year
- In May 2023, IBA unveiled AKURACY, an integrated solution for cardiac PET imaging, during the EACVI meeting in Barcelona. The company emphasized that this represents a unique solution for PET myocardial perfusion imaging
Frequently Asked Questions
The market is segmented based on Segmentation By Type (Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals), Application (Diagnostic and Therapeutic), Source (Nuclear Reactors and Cyclotrons), End User (Hospitals, Diagnostic Centers, Cancer Research Institutes, Ambulatory Surgical Centers, and Others) – Industry Trends and Forecast to 2031
.
The Global Radiopharmaceuticals Market size was valued at USD 15.31 USD Billion in 2023.
The Global Radiopharmaceuticals Market is projected to grow at a CAGR of 6.5% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
